Thursday, January 18, 2024

Venture capital firm General Catalyst’s healthcare arm plans to purchase Akron, Ohio-based Summa Health, and turn it into a for-profit system. CMS issues a final rule that aims to streamline health insurer prior authorizations. And, the FDA approves a groundbreaking CRISPR treatment for a second blood disease. That’s coming up on today’s episode of Gist Healthcare Daily. Hosted on Acast. See acast.com/privacy for more information.

Episode metadata supplied by the publisher feed · Published Jan 18, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

Thursday, January 18, 2024

0:00 8:24

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Gist Healthcare Podcast?

This episode is 8 minutes long.

When was this The Gist Healthcare Podcast episode published?

This episode was published on January 18, 2024.

Can I download this The Gist Healthcare Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!